Stanford University
Showing 401-410 of 1,238 Results
-
Ilang M. Guiroy, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Ilang M. Guiroy is a board-certified, fellowship-trained physician scientist and psychiatrist at Stanford Health Care and Lucile Packard Children’s Hospital Stanford. She is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Guiroy is director of the Guiroy Lab at Stanford. Her research explores maternal-infant mental health and digital mental health, including the use of social media, digital communities, and AI for mental health. She developed a groundbreaking telehealth platform to deliver psychotherapy via group chat to digital communities.
Dr. Guiroy treats mental health conditions in patients throughout the lifespan, from conception to elder age. She has a special interest in infant, child, and maternal mental health and provides medication management during pregnancy, postpartum, and breastfeeding. Dr. Guiroy provides expert support to patients coping with birth trauma, transitioning to motherhood, and fostering infant attachment and maternal bonding. Dr. Guiroy is skilled in over twelve therapy modalities including maternal-infant dyadic therapy, interpersonal therapy (IPT), and cognitive behavioral therapy (CBT).
Dr. Guiroy has published her research in peer-reviewed journals, including Journal of Technology in Behavioral Science and Telemedicine and e-Health. She has also presented to her peers at national conferences for the American Academy of Child and Adolescent Psychiatry (AACAP) and the Society for Digital Mental Health (SDMH).
Dr. Guiroy is a member of the AACAP, the SDMH, the American Psychiatric Association (APA), and the International Marcé Society for Perinatal Mental Health. -
Kritee Gujral
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
Current Role at Stanford- Instructor (Affiliated), Stanford Department of Psychiatry and Behavioral Sciences
- Research Scientist, Stanford Center for Responsible and Effective AI Technology Enhancement (CREATE)
- Researcher & Data Analyst, Stanford-Surgery Policy Improvement Research & Education Center (S-SPIRE) -
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on improving psychiatric care for medically complex patients through integrated behavioral health, medical education, and consultation-liaison psychiatry, with particular emphasis on psychiatry-led education for internal medicine residents, psychiatric interviewing, trauma-informed communication, delirium, catatonia, and psychopharmacology in the medically ill.
-
Divya Gupta, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Divya Gupta is a board-certified, fellowship-trained neurologist with Stanford Health Care. She is a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
As a sleep medicine specialist, Dr. Gupta has expertise caring for a wide range of sleep disorders in children and adults. She develops personalized treatment plans for problems such as insomnia, sleep-related breathing disorders, disruptive nighttime sleep behaviors, and sleep-related movement disorders. She specializes in pediatric neurology and diagnosing and managing developmental disorders in children. Dr. Gupta works closely with patients and families to help improve sleep quality and overall quality of life.
Dr. Gupta is a physician-researcher in the neurology field, focused on studying neurological disorders in children. She has evaluated seizure management, including febrile seizures (convulsions caused by a fever) and severe epilepsy syndromes. She has examined how brain inflammation and genetic conditions affect the brain and sleep. Her recent studies have explored sleep disorders in children living with autism spectrum disorder, investigating the impact of conditions such as obstructive sleep apnea and ways to improve sleep evaluations.
Dr. Gupta has published her findings in the HealthCare Ethics Committee Forum and Annals of the Child Neurology Society. She has also presented her research across the nation at meetings of the American Academy of Neurology, Associated Professional Sleep Societies (SLEEP Meeting), and Child Neurology Society (CNS).
Dr. Gupta is a member of the American Academy of Sleep Medicine (AASM) and Child Neurology Society (CNS). -
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura M. Hack is an Assistant of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System (PAVAHCS). As Associate Director of the Novel & Precision Neurotherapeutics Program at the Stanford Center for Precision Mental Health, Dr. Hack leads a translational, patient-centered research group that designs and implements mechanistic clinical trials for biologically informed subtypes of Mood, Anxiety, and Trauma-related Disorders (MATRDs).
Her work spans repurposed pharmacologic interventions (e.g., guanfacine), neuromodulation techniques (e.g., repetitive transcranial magnetic stimulation [TMS]), and therapies involving altered states of consciousness (i.e., ketamine, MDMA, psilocybin, and anesthesia-induced dreaming). Across these modalities, Dr. Hack's focus is on tailoring treatment based on objective, biologically anchored markers that match the patient’s profile.
Dr. Hack also directs the Stanford Precision Psychiatry Clinic, a high-touch, high-tech consultation service designed to support individuals with a primary diagnosis of major depression and often comorbid MATRDs. This clinic integrates the investigational use of high-definition neuroimaging (personalized brain circuit scores) with symptom profiling, neurocognitive testing, pharmacogenomic analysis, inflammatory biomarkers, and standard blood work. The aim is to generate individualized insights that inform treatment decisions and help patients better understand the biological underpinnings of their condition—often reducing self-blame and empowering engagement in care.
In her role as Deputy Director as well as Ketamine and Education Lead of the Precision Neuromodulation Clinic (PNC) at PAVAHCS, Dr. Hack specializes in delivering evidence-based, FDA-cleared interventions including TMS and intranasal ketamine for Veterans experiencing treatment-resistant depression, frequently in the context of comorbid PTSD.
